Assessing of Humoral Immunity to SARS-COV-2 in Residents of Orenburg During the Epidemic Period

QR Code

Assessing of Humoral Immunity to SARS-COV-2 in Residents of Orenburg During the Epidemic Period

Relevance. The formation of humoral immunity is one of the most important manifestations of the protective mechanism against an infectious disease. The formation of antibodies with neutralizing activity is a key factor in preventing infection.Aims. Analysis of the esults of an ELISA study for the p...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. S. Pankov, S. Yu. Nosyreva, I. F. Karimov, A. G. Korneev, S. D. Borisov
Format:	Article
Language:	Russian
Published:	Numikom LLC 2022-05-01
Series:	Эпидемиология и вакцинопрофилактика
Subjects:	antibodies sars-cov-2 epidemic process seroconversion age group orenburg region
Online Access:	https://www.epidemvac.ru/jour/article/view/1517
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Specific Features of the Spread of New Coronavirus Infection (COVID 19) in Orenburg Region
by: A. S. Pankov, et al.
Published: (2021-07-01)

Retrospective of International Serological Studies on the Formation and Dynamics of the Humoral Immune Response to SARS-CoV-2: from 2020 to 2021
by: E. A. Novikova, et al.
Published: (2021-06-01)

Population immunity to SARS-CoV-2 virus in residents of the Irkutsk Region in the dynamics of the epidemic
by: S. V. Balakhonov, et al.
Published: (2021-10-01)

Postinfectious and Postvaccinal Humoral Immune Response to SARS-CoV-2 in Adults: Qualitative and Quantitative Assessment
by: M. A. Yermalovich, et al.
Published: (2023-07-01)

«DELTA-VAC» SUBUNIT VACCINE INDUCES STRONG HUMORAL IMMUNE RESPONSE AGAINST SARS-COV-2
by: Valentina Sergeevna Nesmeyanova, et al.
Published: (2019-08-01)

Humoral and Cellular Immune Responses to SARS-CoV-2 in Participants with Head and Neck Cancer
by: Luminita Mărutescu, et al.
Published: (2025-06-01)

Age-related features of cancer incidence in Omsk and Orenburg Regions
by: N. G. Shirlina, et al.
Published: (2021-03-01)

Seroprevalence and influencing factors of low-level neutralizing antibodies against SARS-CoV-2 in community residents
by: YUAN Shiying, et al.
Published: (2025-05-01)

The Orenburg Diocesan Council in 1917–1918: Activities and Place in the Structure of Diocesan Administration
by: Ivan E. Astakhov
Published: (2025-06-01)

SARS‐CoV‐2 infection shortly after BNT162b2 vaccination results in high anti‐spike antibody levels in nursing home residents and staff
by: Doris Urlaub, et al.
Published: (2021-12-01)

SARS-CoV-2 spike S2-specific neutralizing antibodies
by: Chia-Jung Li, et al.
Published: (2023-12-01)

Neutralising and Non-neutralising Antibodies to SARS-CoV-2: Role during Infection and in the Evolution of Antigenic structure
by: S. K. Pylaeva, et al.
Published: (2025-01-01)

Total antibodies and neutralizing ability of convalescent sera against three different strains of SARS-CoV-2
by: Natalia V. Palyanova, et al.
Published: (2025-03-01)

Features of the Circulation of ARVI Pathogens During of Emergence and Widespread of SARS-CoV-2 in the 2018–2021
by: E. I. Burtseva, et al.
Published: (2022-09-01)

Optimizing the breadth of SARS-CoV-2-neutralizing antibodies in vivo and in silico
by: Daisuke Kuroda, et al.
Published: (2025-12-01)

Antibody Kinetics of Immunological Memory in SARS-CoV-2-Vaccinated Healthcare Workers—The ORCHESTRA Project
by: Seyedalireza Seyedi, et al.
Published: (2025-06-01)

Characterization of the Binding and Inhibition Mechanisms of a Novel Neutralizing Monoclonal Antibody Targeting the Stem Helix Region in the S2 Subunit of the Spike Protein of SARS-CoV-2
by: Selene Si Ern Tan, et al.
Published: (2025-06-01)

Dynamics of changes in population immunity to the SARS-CоV-2 virus in residents the Irkutsk region in the context of the COVID-19 pandemic
by: S. V. Balakhonov, et al.
Published: (2021-05-01)

Formation of Herd Immunity to SARS-CoV-2 in the Population of Moscow
by: M A Godkov, et al.
Published: (2022-03-01)

Neutralizing Antibody Spectrum in COVID-19 Patients who Became Ill During the Circulation of Different SARS-CoV-2 Variants
by: S. K. Pylaeva, et al.
Published: (2024-11-01)

Assessment of T-cell immunity to SARS-CoV-2 in COVID-19 convalescents and vaccinated subjects, using TigraTest<sup>®</sup> SARS-CoV-2 ELISPOT kit
by: D. A. Poteryaev, et al.
Published: (2021-10-01)

Studying Humoral Immune Response at Mild and Asymptomatic COVID-19 Forms
by: S. V. Balakhonov, et al.
Published: (2020-11-01)

Dynamics of humoral immunity during natural SARS-CoV-2 infection and/or after vaccination with the ‘Sputnik V’ vaccine
by: A. V. Ivanov, et al.
Published: (2024-11-01)

Anti-SARS-CoV-2 spike receptor binding domain (S-RBD) IgG antibodies following CoronaVac administration: a longitudinal study. Anti-SARS-CoV-2 S-RBD IgG antibodies
by: Ph. Liana, et al.
Published: (2023-02-01)

Features of humoral immunity after COVID-19
by: E. V. Semenova, et al.
Published: (2022-04-01)

SARS-CoV-2 hijacks neutralizing dimeric IgA for nasal infection and injury in Syrian hamsters1
by: Biao Zhou, et al.
Published: (2023-12-01)

Interaction of SARS-CoV-2 and SARS-CoV-2 vaccines with renin angiotensin aldosterone system, clinical outcomes, and angiotensin (1-7) as a physiological treatment recommendation: hypothesis and theory article
by: Ali Rıza Aktaş
Published: (2025-07-01)

Antibodies to the receptor-binding domain of the SARS-Cov-2 spike protein: association with age, pneumonia, duration of the period after COVID-19
by: E. A. Kolosova, et al.
Published: (2022-04-01)

Structure of herd immunity to SARS-COV-2 in the Krasnoyarsk region population in the COVID-19 epidemic
by: A. Yu. Popova, et al.
Published: (2021-08-01)

Serological Surveillance of Betacoronaviruses in Bat Guano Collectors: Pre-COVID-19 Pandemic and Post-SARS-CoV-2 Emergence
by: Sasiprapa Ninwattana, et al.
Published: (2025-06-01)

Experience in Studying Seroprevalence to SARS-CoV-2 Virus in the Population of the Irkutsk Region during COVID-19 Outbreak
by: A. Yu. Popova, et al.
Published: (2020-10-01)

Durability of Antibody Responses to SARS-CoV-2 Vaccination over 12 Months in Pediatric Inflammatory Bowel Disease
by: Sally J. Lawrence, et al.
Published: (2025-05-01)

Influenza vaccine is able to induce post-infection antibodies to SARS-CoV-2 in medical staff
by: M. P. Kostinov, et al.
Published: (2025-01-01)

Is The SARS-CoV2 Evolved in Human Being: A prospective Genetic Analysis
by: Salvatore Dimonte, et al.
Published: (2020-12-01)

Socio-Demographic Profile of Provincial Journalists in Late 1920s to Early 1930s (Orenburg Region)
by: D. A. Safonov
Published: (2024-08-01)

Cancer incidence over the last decade in Omsk and Orenburg regions: a descriptive study
by: N. G. Shirlina, et al.
Published: (2020-06-01)

Biological Analysis for Counterfeit Detection of Orenburg Downy Shawls
by: Ol'ga F. Chernova, et al.
Published: (2018-06-01)

Assessment of serological tests for antibodies to different antigens of the SARS-CoV-2 virus: comparison of six immunoassays
by: V. V. Belyakova, et al.
Published: (2021-12-01)

Correlation between SARS-CoV-2-specific antibody titers and the hormones DHEA, cortisol, testosterone, and progesterone
by: Tanja Karl, et al.
Published: (2025-07-01)

Neutralization Activity of Standard and Hyperimmune Intravenous Immunoglobulins Against Recently Circulating SARS-CoV-2 Variants
by: Dongxiao Liu, et al.
Published: (2025-07-01)